TNIK's emerging role in cancer, metabolism, and age-related diseases.

IF 13.9 1区 医学 Q1 PHARMACOLOGY & PHARMACY Trends in pharmacological sciences Pub Date : 2024-06-01 Epub Date: 2024-05-21 DOI:10.1016/j.tips.2024.04.010
Collin Y Ewald, Fadi E Pulous, Sarah Wing Yan Lok, Frank W Pun, Alex Aliper, Feng Ren, Alex Zhavoronkov
{"title":"TNIK's emerging role in cancer, metabolism, and age-related diseases.","authors":"Collin Y Ewald, Fadi E Pulous, Sarah Wing Yan Lok, Frank W Pun, Alex Aliper, Feng Ren, Alex Zhavoronkov","doi":"10.1016/j.tips.2024.04.010","DOIUrl":null,"url":null,"abstract":"<p><p>Traf2- and Nck-interacting kinase (TNIK) has emerged as a key regulator of pathological metabolic signaling in several diseases and is a promising drug target. Originally studied for its role in cell migration and proliferation, TNIK possesses several newly identified functions that drive the pathogenesis of multiple diseases. Specifically, we evaluate TNIK's newfound roles in cancer, metabolic disorders, and neuronal function. We emphasize the implications of TNIK signaling in metabolic signaling and evaluate the translational potential of these discoveries. We also highlight how TNIK's role in many biological processes converges upon several hallmarks of aging. We conclude by discussing the therapeutic landscape of TNIK-targeting drugs and the recent success of clinical trials targeting TNIK.</p>","PeriodicalId":23250,"journal":{"name":"Trends in pharmacological sciences","volume":null,"pages":null},"PeriodicalIF":13.9000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.tips.2024.04.010","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/21 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Traf2- and Nck-interacting kinase (TNIK) has emerged as a key regulator of pathological metabolic signaling in several diseases and is a promising drug target. Originally studied for its role in cell migration and proliferation, TNIK possesses several newly identified functions that drive the pathogenesis of multiple diseases. Specifically, we evaluate TNIK's newfound roles in cancer, metabolic disorders, and neuronal function. We emphasize the implications of TNIK signaling in metabolic signaling and evaluate the translational potential of these discoveries. We also highlight how TNIK's role in many biological processes converges upon several hallmarks of aging. We conclude by discussing the therapeutic landscape of TNIK-targeting drugs and the recent success of clinical trials targeting TNIK.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
TNIK 在癌症、新陈代谢和老年相关疾病中的新作用。
Traf2- 和 Nck-互作激酶(TNIK)已成为多种疾病的病理代谢信号转导的关键调节因子,也是一个很有前景的药物靶点。TNIK 最初是因其在细胞迁移和增殖中的作用而被研究的,现在它具有几种新发现的功能,可驱动多种疾病的发病机制。具体而言,我们将评估 TNIK 在癌症、代谢紊乱和神经元功能中的新发现作用。我们强调了 TNIK 信号在代谢信号中的影响,并评估了这些发现的转化潜力。我们还强调了 TNIK 在许多生物过程中的作用如何与衰老的几个特征相融合。最后,我们将讨论 TNIK 靶向药物的治疗前景以及最近针对 TNIK 的临床试验取得的成功。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
23.90
自引率
0.70%
发文量
132
审稿时长
6-12 weeks
期刊介绍: Trends in Pharmacological Sciences (TIPS) is a monthly peer-reviewed reviews journal that focuses on a wide range of topics in pharmacology, pharmacy, pharmaceutics, and toxicology. Launched in 1979, TIPS publishes concise articles discussing the latest advancements in pharmacology and therapeutics research. The journal encourages submissions that align with its core themes while also being open to articles on the biopharma regulatory landscape, science policy and regulation, and bioethics. Each issue of TIPS provides a platform for experts to share their insights and perspectives on the most exciting developments in the field. Through rigorous peer review, the journal ensures the quality and reliability of published articles. Authors are invited to contribute articles that contribute to the understanding of pharmacology and its applications in various domains. Whether it's exploring innovative drug therapies or discussing the ethical considerations of pharmaceutical research, TIPS provides a valuable resource for researchers, practitioners, and policymakers in the pharmacological sciences.
期刊最新文献
DOT1L: orchestrating methylation-dependent radiotheRAPy responses via BRCA1. Targeting TRPM channels for cerebral ischemia-reperfusion injury. Targeting white adipose tissue to combat insulin resistance. Neurofilament light chain as a biomarker of chemotherapy-induced peripheral neuropathy. Spare the pain for your gut Treg cells!
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1